CIK 0001585608
- Non-accelerated filer
- Smaller reporting company
Jaguar Health, Inc.
Sign in to watch- Ticker
- JAGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-371-8300
- Business address
- 200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
- Former names
- Jaguar Animal Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-17 | King Steven R. See Remarks | Option exercise · Restricted stock units | −612 | 612 | ||
| 2024-05-17 | CONTE LISA A CEO and President | Option exercise | +2,695 | 7,295 | ||
| 2024-05-17 | CONTE LISA A CEO and President | Option exercise · Restricted stock units | −2,695 | 2,694 | ||
| 2024-04-05 | Chaturvedi Pravin R Chief Scientific Officer | Option exercise | +134 | 1,270 | ||
| 2024-04-05 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award · Restricted stock units | −134 | 0 | ||
| 2024-04-05 | Wolin Jonathan S. Chief of Staff, CCO & GC | Option exercise | +89 | 1,141 | ||
| 2024-04-05 | Wolin Jonathan S. Chief of Staff, CCO & GC | Grant or award · Restricted stock units | −89 | 0 | ||
| 2024-04-05 | Lizak Carol R. Chief Financial Officer | Option exercise | +60 | 611 | ||
| 2024-04-05 | Lizak Carol R. Chief Financial Officer | Grant or award · Restricted stock units | −60 | 0 | ||
| 2024-04-05 | King Steven R. See Remarks | Option exercise | +178 | 1,144 | ||
| 2024-04-05 | King Steven R. See Remarks | Grant or award · Restricted stock units | −178 | 0 | ||
| 2024-04-05 | CONTE LISA A CEO and President | Option exercise | +600 | 4,600 | ||
| 2024-04-05 | CONTE LISA A CEO and President | Grant or award · Restricted stock units | −600 | 0 | ||
| 2023-08-14 | Jayasuriya Anula Director | Grant or award | +68,568 | 70,286 | ||
| 2023-08-14 | Siegel Jonathan B. Director | Grant or award | +68,568 | 69,874 | ||
| 2023-08-14 | MICEK JOHN Director | Grant or award | +68,568 | 80,701 | ||
| 2023-08-14 | BOCHNOWSKI JAMES J Director | Grant or award | +76,613 | 78,876 | ||
| 2023-08-14 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award | +204,192 | 205,328 | ||
| 2023-08-14 | Wolin Jonathan S. Chief of Staff, CCO & GC | Grant or award | +196,628 | 197,680 | ||
| 2023-08-14 | Lizak Carol R. Chief Financial Officer | Grant or award | +142,088 | 142,745 |
Page 5 of 10 · 185 trades